xbrl.rienks.biz
English 
Nederlands
Français
Deutsch Fornix BioSciences N.V.
| Adres | Beurs | Aandeel (09-02-2012: 17:25:00) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
4.84%Industrie: Welzijn en gezondheidszorg
Sector: biotechnologie
Companies engaged in research into and development of biological substances for the purposes of drug discovery and diagnostic development, and which derive the majority of their revenue from either the sale or licensing of these drugs and diagnostic tools.
| Crucell N.V. | (CRXL) | biotechnologie |
| Fornix BioSciences N.V. | (FORBI) | biotechnologie |
| Galapagos | (GLPGA) | biotechnologie |
| Pharming Group N.V. | (PHARM) | biotechnologie |
Einde Boekjaar: 31-12
| English | Dutch | |
| Annual Report 2007 (11.84 MB) (KPMG) Annual Report 2006 (4.38 MB) (KPMG) Annual Report 2005 (2.97 MB) (KPMG) Annual Report 2004 (3.38 MB) (KPMG) Annual Report 2003 (2.66 MB) (KPMG) Annual Report 2002 (3.37 MB) (KPMG) | Jaarverslag 2007 (11.23 MB) (KPMG) Jaarverslag 2006 (4.28 MB) (KPMG) Jaarverslag 2005 (2.91 MB) (KPMG) Jaarverslag 2004 (3.62 MB) (KPMG) Jaarverslag 2003 (2.67 MB) (KPMG) Jaarverslag 2002 (3.53 MB) (KPMG) |
Nieuws
Financiële agenda
| Jaarcijfers | Kwartaalcijfers | Analistenbijeenkomst |
|---|---|---|
| 16-03-2006 | Q1 - | - |
| Q2 14-08-2006 | - | |
| AVA | Q3 - | - |
| - | Q4 - | - |
Jaarrekening Fornix BioSciences N.V.